Opportunities: Poseida Therapeutics Inc (PSTX) Stock in the Short-Term and the Long-Term
H.C. Wainwright raised the price target for the Poseida Therapeutics Inc (NASDAQ:PSTX) stock to “a Buy”. The rating was released on January 04, 2023, according to finviz. The research report from BTIG Research has initiated the stock to Buy, with a price target set at $40. In their research brief published August 04, 2020, Piper […]
Poseida Therapeutics Inc (PSTX) Stock: Thought Concerns
H.C. Wainwright raised the price target for the Poseida Therapeutics Inc (NASDAQ:PSTX) stock to “a Buy”. The rating was released on January 04, 2023, according to finviz. The research report from BTIG Research has initiated the stock to Buy, with a price target set at $40. In their research brief published August 04, 2020, Piper […]
Poseida Therapeutics Inc (NASDAQ:PSTX) stock is trading -52.69 percent below its 52-week high
H.C. Wainwright raised the price target for the Poseida Therapeutics Inc (NASDAQ:PSTX) stock to “a Buy”. The rating was released on January 04, 2023, according to finviz. The research report from BTIG Research has initiated the stock to Buy, with a price target set at $40. In their research brief published August 04, 2020, Piper […]
Is Poseida Therapeutics Inc (PSTX) Stock worth its current valuation?
H.C. Wainwright raised the price target for the Poseida Therapeutics Inc (NASDAQ:PSTX) stock to “a Buy”. The rating was released on January 04, 2023, according to finviz. The research report from BTIG Research has initiated the stock to Buy, with a price target set at $40. In their research brief published August 04, 2020, Piper […]
